References (Supplied by CrossRef)
Four‐year longitudinal index stability data from stratify‐2 support the clinical utility of index for risk stratification of natalizumab‐associated progressive multifocal leukoencephalopathy
Campagnolo D. et al.
An evaluation of the longitudinal stability of anti‐JC virus (JCV) antibody levels in patients with multiple sclerosis (MS)
Donovan E. et al.
Stratification and monitoring of natalizumab‐associated progressive multifocal leukoencephalopathy risk: Recommendations from an expert group
McGuigan C. et al.
Journal of Neurology, Neurosurgery and Psychiatry 2016